Boundless Bio, Inc.
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 7.31% | -0.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.34% | -3.49% | |||
| Operating Income | 2.34% | 3.49% | |||
| Income Before Tax | 0.37% | 2.75% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.37% | 2.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.37% | 2.75% | |||
| EBIT | 2.34% | 3.49% | |||
| EBITDA | 2.55% | 3.52% | |||
| EPS Basic | 0.50% | 3.76% | |||
| Normalized Basic EPS | 0.52% | 3.76% | |||
| EPS Diluted | 0.50% | 3.76% | |||
| Normalized Diluted EPS | 0.52% | 3.76% | |||
| Average Basic Shares Outstanding | 0.13% | 1.05% | |||
| Average Diluted Shares Outstanding | 0.13% | 1.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||